• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 2 of 2

  • Page:
  • 1

Efficacy and Safety of Tolebrutinib Versus Placebo in Primary Progressive Multiple Sclerosis: Results from the Phase Three PERSEUS Trial

Author:Fox, Robert   Bar-Or, Amit   Vermersch, Patrick   Oreja Guevara, Celia   Traboulsee, Anthony   Giovannoni, Gavin   Syed, Sana   Sun, Furong   Salloum, Naji   Turner, Timothy   Wallstroem, Erik   Reich, Daniel   

Session Name:PL6: Contemporary Clinical Issues Plenary Session  

Topic:Multiple Sclerosis  

Program Number:PL6.003  

Author Institution:Cleveland Clinic, Cleveland, OH  University of Pennsylvania, Philadelphia, PA  University of Lille, Lille, France  Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain  University of British Columbia, Vancouver, BC, Canada  Queen Mary University London, London, United Kingdom  Sanofi , Cambridge, MA  Sanofi, Morristown, NJ  Sanofi, CHILLY-MAZARIN, France  Sanofi, Cambridge, MA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, MD  

  • View Abstract
  • View Disclosure

Blood Levels of Immune Cells, Immunoglobulins, and Platelets in the Phase Three HERCULES and GEMINI Trials of Tolebrutinib in Non-relapsing Secondary Progressive Multiple Sclerosis and Relapsing Multiple Sclerosis

Author:Oreja Guevara, Celia   Bar-Or, Amit   Wiendl, Heinz   Kim, Ho Jin   Syed, Sana   Xu, Zhixing   Vargas, Wendy   Maxwell, Christina   Hincelin-Mery, Agnes   Djukic, Biljana   Turner, Timothy   Oh, Jiwon   Fox, Robert   

Session Name:P9: Multiple Sclerosis: Clinical Trials 2  

Topic:Multiple Sclerosis  

Program Number:P9.001  

Author Institution:Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain  University of Pennsylvania, Philadelphia, PA  University of Freiburg, Freiburg im Breisgau, Germany  National Cancer Center, Goyang, Korea, Republic of  Sanofi, Cambridge, MA  Sanofi, Edison, NJ  Sanofi, Bridgewater, NJ  Sanofi, Mullica Hill, NJ  Sanofi, Vitry Sur Seine, France  St Michael's Hospital, Toronto, ON, Canada  Cleveland Clinic, Cleveland, OH  

  • View Abstract
  • View Disclosure

Displaying 1 - 2 of 2

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com